350
Participants
Start Date
August 31, 1996
Primary Completion Date
March 31, 2002
lomustine
procarbazine hydrochloride
vincristine sulfate
radiation therapy
Hopital Universitaire Erasme, Brussels
Academisch Ziekenhuis der Vrije Universiteit Brussel, Brussels (Bruxelles)
Instituto Portugues de Oncologia de Francisco Gentil, Lisbon
National Institute of Neurosurgery, Budapest
Hopital de Jolimont, Haine-Saint-Paul
CHU de la Timone, Marseille
C.H.R. de Nimes - Hopital Caremeau, Nîmes
Centre Eugene Marquis, Rennes
Azienda Ospedaliera di Padova, Padova (Padua)
Universita di Padova, Padua
CRLCC Nantes - Atlantique, Nantes-Saint Herblain
CHU de Nancy - Hopital Neurologique, Nancy
Centre Hospitalier Regional de Lille, Lille
CHU Pitie-Salpetriere, Paris
Kaiser Franz Josef Hospital, Vienna (Wien)
U.Z. Gasthuisberg, Leuven
Turku University Central Hospital, Turku
Hopital Pasteur, Nice
Centre Antoine Lacassagne, Nice
Institut Gustave Roussy, Villejuif
Neurologische Klinik der Henriettenstiftung, Hanover
Klinikum der Friedrich-Schiller Universitaet Jena, Jena
Medisch Centrum Haaglanden, 's-Gravenhage (Den Haag, the Hague)
Vrije Universiteit Medisch Centrum, Amsterdam
Academisch Medisch Centrum, Amsterdam
Academisch Ziekenhuis Groningen, Groningen
University Medical Center Nijmegen, Nijmegen
Rotterdam Cancer Institute, Rotterdam
St. Elisabeth Ziekenhuis, Tilburg
Dr. Bernard Verbeeten Instituut, Tilburg
Academisch Ziekenhuis Utrecht, Utrecht
University Hospital of Linkoping, Linköping
Umea Universitet, Umeå
Centre Hospitalier Universitaire Vaudois, Lausanne
Nottingham General Hospital, Nottingham
Nottingham City Hospital NHS Trust, Nottingham
Queen's Medical Centre, Nottingham
Royal South Hants Hospital, Southampton
Southampton General Hospital, Southampton
Royal Marsden Hospital, Sutton
Collaborators (1)
Medical Research Council
OTHER_GOV
European Organisation for Research and Treatment of Cancer - EORTC
NETWORK